More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

Lower oral microbiome α-diversity was linked to an increased prevalence of RA, with compositional differences in β-diversity found between those with vs without RA.

A study headed by researchers at the University of Leeds has found that changes in the makeup of the gut microbiome are linked to the onset of clinically evident rheumatoid arthritis (RA) in those at ...